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Abstract
Background: Parkinson’s disease (PD) is a severe neurodegenerative disease associated with loss of dopaminergic
neurons. Derivation of dopaminergic neurons from human embryonic stem cells (hESCs) could provide new
therapeutic options for PD therapy. Dopaminergic neurons are derived from SOX− floor plate (FP) cells during
embryonic development in many species and in human cell culture in vitro. Early treatment with sonic hedgehog
(Shh) has been reported to efficiently convert hESCs into FP lineages.
Methods: In this study, we attempted to utilize a Shh-free approach in deriving SOX1− FP cells from hESCs in vitro.
Neuroectoderm conversion from hESCs was achieved with dual inhibition of the BMP4 (LDN193189) and TGF-β
signaling pathways (SB431542) for 24 h under defined culture conditions.
Results: Following a further 5 days of treatment with LDN193189 or LDN193189 + SB431542, SOX1− FP cells constituted
70–80 % of the entire cell population. Upon treatment with Shh and FGF8, the SOX1− FP cells were efficiently converted
to functional Nurr1+ and TH+ dopaminergic cells (patterning), which constituted more than 98 % of the entire
cell population. However, when the same growth factors were applied to SOX1+ cells, only less than 4 % of the
cells became Nurr1+, indicating that patterning was effective only if SOX1 expression was down-regulated. After
transplanting the Nurr1+ and TH+ cells into a hemiparkinsonian rat model, significant improvements were
observed in amphetamine induced ipslateral rotations, apomorphine induced contra-lateral rotations and Rota
rod motor tests over a duration of 8 weeks.
Conclusions: Our findings thus provide a convenient approach to FP development and functional dopaminergic
neuron derivation.
Keywords: Human embryonic stem cells, Neural conversion, Floor plate, LDN193189, SB431541, PD173074,
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Background
Parkinson’s disease (PD) is the second most common
central nervous system neurodegenerative disease
and the most common sub-cortical neurodegenera-
tive disease [1]. The prevalence of PD is generally
estimated at 0.3 % of the entire population, 1 % of
the population over 60, and 4 % of those over 80
[2]. PD is caused by loss of dopaminergic neurons
from the substantia nigra and disease severity is cor-
related to the percentage of dopaminergic neuronal
loss [3]. PD in most people is idiopathic but envir-
onmental or genetic factors may contribute to the
onset of dopaminergic neuron loss in certain cases.
Currently, there is no proven preventative therapy or
cure for this disease.
PD is typically managed pharmacologically with
dopaminergic agonist replacement or by increasing
production of dopamine in surviving dopaminergic
neurons through administration of the dopamine
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precursor, L-3,4-dihydroxyphenylalanine (L-DOPA). In
certain cases, deep brain stimulation and fetal tissue
transplantation have been utilized in the clinical man-
agement of PD [4]. The transplantation of donor fetal
tissue is however associated with concerns regarding
supply of sufficient quantities of tissue, inter-batch
variability, safety and ethics. Human embryonic stem
cells (hESCs) hold great promise in regenerative medi-
cine. There is potential for application in PD therapy
as hESCs have been differentiated into functional
dopaminergic neurons with various protocols [5–7].
Of particular interest is the study by Kriks et al. that
reported a floor plate (FP)-based strategy for the der-
ivation of human DA neurons within 25 days [7],
based on the earlier FP induction protocol developed
by Fasano et al. that involved early sonic hedgehog
(Shh) exposure [8].
As an alternative to Shh-induced FP induction, Teillet
et al. showed that the FP develops in a cell-
autonomous manner in the absence of a notochord,
providing evidence that the lineage fate of some FP
cells derived from the chordoneural hinge is predeter-
mined [9]. In this study, we employed a Shh-free ap-
proach in deriving FP cells with BMP and TGF-β dual
inhibition. To determine the optimal timing of FP in-
duction for our in vitro system, we utilized the dynam-
ics of SOX1 expression as an indicator. Studies have
shown that SOX1 is restricted to neural folds at the
2nd somite stage and restricted to the neural tube at
the 10th-12th somite stages. At the 20th somite stage,
SOX1 is down-regulated in the FP of the neural tube.
Specifically, cells occupying the lateral regions of the
FP express SOX1, whereas cells occupying the medial
region do not [10, 11]. However, little is known about
how SOX1 is associated with FP cells derived in situ
within the developing human embryo or equivalent in
vitro model systems.
In this study, we report efficient induction of SOX1−
FP cells for the derivation of dopaminergic neurons from
hESCs. Dissociation of hESC into a single-cell suspen-
sion was carried out, followed by treatment (for 24 h)
with a BMP4 inhibitor, LDN193189, and a TGF-β inhibi-
tor, SB431542, (dual restriction) for neuroectoderm con-
version under defined culture conditions. The cells were
then subsequently cultured in the presence of
LDN193189 and SB431542 (dual inhibition) for 5 days
to achieve a SOX1− medial FP cell population. In
addition, 5 days of treatment with FGF2 or transient
treatment with its inhibitor PD173074 was investigated
in our platform (patterning). We found that when the
cells are SOX1+, treatment with Shh and FGF8 only
yielded less than 4 % of Nurr1+ cells. It was only after
SOX1 expression was down-regulated, that Shh and
FGF8 treatment yielded more than 90 % Nurr1+ cells.
Methods
Cell lines, culture media and supplements, labware
consumables and reagents
Undifferentiated hESC of the H1 and H9 line were pur-
chased from Wicell Inc. (Madison, WI, USA). Unless
otherwise stated, all culture media and supplements in-
cluding serum and trypsin were purchased from Gibco
BRL Inc. (Grand Island, NY, USA); all cell culture plastic
labware consumables were purchased from BD Bioscience
Inc. (Franklin Lakes, NJ, USA); and all reagents including
growth factors were purchased from Sigma-Aldrich Inc.
(St Louis, MO, USA). Cell cultures were carried out at
37 °C within a humidified 5 % CO2 incubator (Heraeus
GmbH, Hanau, Germany).
Cell culture and GFP labeling
H1 and H9 hESCs were continuously co-cultured
under Mytomycin-C inactivated Mouse Embryonic
Fibroblast (MEF) feeders, as previously described [12].
The hESCs culture medium is composed of Dulbecco’s
modified Eagle’s medium (DMEM) F-12 supplemented
with 20 % (v/v) knock-out serum replacement (KSR),
1 mM L-glutamine, 0.1 mM β-mercaptoethanol, 1 %
(v/v) non-essential amino acid and 4 ng/ml recombin-
ant basic fibroblast growth factor (rFGF2). Culture
media were changed every day and cells were sub-
cultured at 5–6 days intervals. For labeling, hESCs
colonies were treated with 2 mg/ml collagenase IV for
20 min to allow the colonies to detach from the MEF
feeders. The floating colonies were then collected and
dissociated with trypsin/enzyme free cell dissociation
buffer mixture (3:7) in the presence of Y-27632. A
plasmid vector carrying the GFP gene was incubated
with the hESCs for 24 h in Ultra-low Attachment
plates. Transfected cells were then seeded again on
MEF feeder layers for expansion from single cells to
colonies. Green-fluorescent colonies were manually
selected under fluorescent microscopy for expansion
and differentiation.
Induction of FP neurons and patterning
hESCs were detached with 2 mg/ml collagenase type IV
for 20mins and floating colonies were collected. The pel-
lets were then dissociated with trypsin/enzyme free cell
dissociation buffer mixture (3:7) in the presence of Y-
27632. Dissociated cells were then re-suspended into
DMEM/F-12 medium supplemented with 20 % (v/v)
KSR containing 2nM LDN193189 for single restriction
or 2nM LDN193189 and 10 μM SB431542 for dual re-
striction for 24 h on fibronectin-coated plates. For FP in-
duction, cells were cultured in neural basal medium
(NB, Life technologies Inc. Grand Island, NY, USA) sup-
plemented with 1 mM L-glutamine, 1 % (v/v) non-
essential amino acid, 1 % (v/v) N2 supplement with or
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without 0.5nM LDN193189 or 10 μM SB431542 for an-
other 5 days. The FGF2 inhibitor, PD173074 (1 nM), was
added immediately after dual restriction for 24 h only
for lateral FP cell induction. For patterning, cells were
subsequently cultured in NB supplemented with 1 % (v/v)
NEAA, 1 mM L-glutamine, 1 % (v/v) B27 supplement,
200 ng/ml Shh, and 100 ng/ml FGF8. Shh and FGF8 were
then withdrawn and replaced with 20 ng/ml brain derived
neurotrophic factor (BDNF) and 20 ng/ml glial cell derived
neurotrophic factor (GDNF), 1 μM Transforming growth
factor beta-3, 200 μM ascorbic acid and 1 mM Dibutyryl
cyclic adenosine monophosphate (dcAMP), to maintain the
differentiated cells [13].
Gene expression analysis by polymerase chain reaction
mRNA was extracted from samples using Qiagen
RNeasy® Mini Kits (Qiagen Inc., Hilden, Germany). Fol-
lowing the manufacture’s instructions, total mRNA was
immediately quantified by nanodrop and 2 μl of each
mRNA sample was loaded to a 1.5 % agarose gel for in-
tegrity checking. 500 ng of mRNA was reverse tran-
scribed to cDNA using the Biorad iScript™ cDNA
synthesis kits (Biorad Inc., Hercules, CA, USA). Briefly,
40 μl of cDNA was synthesized with programmed
temperature changes of 5 min at 25 °C, then 30 min at
42 °C and followed by 85 °C for 5 min to heat-inactivate
the reverse transcriptase. For qRT-PCR, 20 μl volume of
reaction mix was utilized (including 10 μl Fast SYBR®
Green Master Mix (2X) (Life technologies Inc. Grand
Island, NY, USA), 5nM forward and reverse primers
0.4 μl each, and RNAase free water). cDNA was dena-
tured at 95 °C for 10mins, followed by 40 cycles of de-
naturation at 95 °C for 10 s and 60 °C for 1 min. All
runs were performed on a StepOnePlus™ Real-Time PCR
System (Life technologies Inc. Grand Island, NY, USA)
with GAPDH utilized as the loading control. Fold differ-
ences were calculated relative to control samples. All
primers utilized are listed in Additional file 1: Table S1.
For conventional PCR, a volume of 20 μl was utilized
(including 10 μl Fermentas Master Mix (2X) (Thermo-
Scientific Inc., Waltham, MA, USA), 25nM forward and
reverse primers 0.4 μl each, and RNAase free water).
The PCR product was loaded on a 1.5 % agarose gel and
imaged with a Bio-rad Gel-Doc system (Biorad Inc.,
Hercules, CA, USA).
Flow cytometry
Cells were detached by trypsinization for 5 min at 37 °C.
After fixation in 4 % (w/v) PFA for 10 min at room
temperature, the cells were immediately chilled on ice for
1 min, followed by 10mins permeabilization in 0.2 % Triton
X-100 in 1X PBS. The cells were then incubated with the
appropriate primary antibodies for 4 h at room temperature
followed by incubation with corresponding secondary
antibodies for 1 h, prior to analysis with a CyAn™ Flow
Cytometer (Beckman-Coulter Inc., Indianapolis, IN, USA).
All secondary antibodies used were tested for cross reactiv-
ity and non-specific immunoreactivity. Approximately,
10,000 cells were gated for analyzing each marker.
Immunocytochemistry
Cells/brain slices were washed with 1X phosphate buff-
ered saline (PBS) three times and fixed with 4 % (w/v)
Paraformaldehyde (PFA) for 10mins at room
temperature. Following 10mins permeabilization with
0.2 % Triton X-100 in PBS, the cells were blocked for
1 h with 5 % (v/v) goat serum and 2 % (w/v) bovine
serum albumin (BSA). Diluted primary antibodies were
then added to the culture and incubated at 4 °C over-
night. After 4 washes with 1X PBS, diluted secondary
antibodies against the specific primary antibodies were
added and incubated in the dark at room temperature
for 1 h. All secondary antibodies used were tested for
cross reactivity and nonspecific immunoreactivity. The
nuclear stain DAPI was added 10mins prior to the final
wash. Images were captured under fluorescence micros-
copy. The antibodies used are listed in Additional file 2:
Table S2.
Live imaging analysis for neurite outgrowth
Differentiating dopaminergic cells from monolayer cul-
ture of FP origin were analyzed for neurite outgrowth.
Cells generated by a neurosphere protocol were imaged
together for comparison [14]. Differentiating dopamin-
ergic neurons in 24-well plates were continuously
cultured in a Cell IQ Imagen system (Chip-Man Tech-
nologies INC., Tampere, Finland) for 5 days in a Cell IQ
incubator with 5 % CO2 mixed with air at 37 °C. 2 × 2
grid images were sampled continuously every 15 min on
selected colonies collected over a period of 5 days with
10X magnification using the Cell IQ Imagen system.
Superimposed images were then analyzed using the
Neurite Finder™ module of the Cell IQ Analyser.
In vitro patch clamp
Differentiated dopaminergic cells were immersed in an
external solution of 125 mM NaCl, 3 mM KCl, 1.25 mM
NaH2PO4, 1.5 mM MgCl2, 2 mM CaCl2, 24 mM
NaHCO3, and 10 mM D-Glucose, with pH adjusted to
7.4. Whole-cell voltage clamping was conducted with
the membrane potential clamped at -60 mV as the rest-
ing potential of the differentiated neurons. The currents
were recorded with borosilicate pipettes with resistances
of 2–6MΩ, which were pulled from borosilicate glass ca-
pillaries with a Flaming Brown micropipette puller. The
pipettes were filled with an internal solution with the
same composition as the external solution. Transplanted
neurons were clamped using a MultiClamp 700A
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amplifier in conjunction with a Digidata 1322A interface
(Molecular Devices Inc., Sunnyvale, CA, USA). Currents
were recorded and analyzed using the pCLAMP software
(Molecular Devices Inc., Sunnyvale, CA, USA).
Dopamine secretion assay
Dopamine secretion into the culture media was analyzed
using a Dopamine ELISA Kit (GenWay Biotech Inc., San
Diego, CA, USA) following the manufacture’s instruc-
tions with slight modifications. For amantadine treated
samples, 5 or 10 μM of amantadine was added to the
culture media. Culture media were collected every 3 days
after induction for quantification of dopamine secretion.
Briefly, dopamine from culture media was first extracted
with 12 well pre-coated extraction plates. Following a
few washes, bound dopamine was extracted by 200 μl of
release buffer. Enzyme solution, 100 μl of the extracted
samples and dopamine anti-serum were added to pre-
coated 96 well plates and incubated for 2 h at room
temperature. Enzyme conjugate and PNPP substrate solu-
tion were added sequentially with washes in-between. The
reaction was stopped by addition of PNPP stop solution
and absorbance of samples were read at 405 nm using
Infinite™ 200 plate readers (Tecan Inc., Männedorf,
Switzerland). The amounts of secreted dopamine were cal-
culated based on a standard curve plotted with a series of
known dopamine dilutions supplied by the manufacturer.
Transplantation into Hemi-Parkinsonian rats, behavioral
analysis, patch clamp and histological staining
Sprague Dawley rats were purchased from the animal hold-
ing unit (AHU) of the National University of Singapore,
and were housed in biological safety level 2 pathogen-free
facilities with free access to food and water under a 12 h
light/dark cycle, and with standard room temperature of
23 ± 1 °C. Ethical approval for all animal experiments were
obtained from the Institutional Animal Care and Use Com-
mittee (IACUC) of the National University of Singapore.
All animal studies were in compliance with the “Animal
Research: Reporting In Vivo Experiments” (ARRIVE) guide-
lines. Animals (250 g) were anaesthetized and immobilized
with a stereotactic instrument. 20 μg of 6-OHDA was
stereotaxically injected at the bregma (AP +1.00 mm,
ML +3.00 mm, DV +4.5 mm), at a concentration of
5 μg/μl with the aid of the Angle Two Software for
unilateral lesion. Only animals with a mean contralat-
eral rotation score of 7 or more body turns per minute
at 3 weeks post-lesion were included in the study. Ini-
tially, lesions were created on 25 rats. However by
3 weeks post-lesion, only 12 rats that met the criteria
of >7 rounds of contra-literal rotation induced by
0.5 mg/lg apomorphine were utilized for cell trans-
plantation. At 12 days post-lesion, dopaminergic cells
(250,000 cells/4 μl) were grafted into the same lesion
site. 0.5 mg/kg of apomorphine or 0.25 mg/kg of am-
phetamine were injected subcutaneously or intraperi-
toneally and their contralateral and ipslateral rotation
behavior was monitored over a 45 min period using an
EthoVsion XT system (Noldus Inc., Wageningen,
Netherlands). Rotation scores were expressed as full
body turns per minute. To measure balance and coordin-
ation, animals were placed on a horizontally rotating rod
that accelerated from 2rmp to 40 rpm within 2 min. The la-
tency of fall off from the rod was recorded for 6 trials with
10 min rest between each trial.
Eight weeks after transplantation of GFP-labeled cells,
brain samples were sectioned at 200 μm with a vibra-
tome in 10 % (v/v) glycerol in PBS. Whole-cell voltage
clamping was conducted with the membrane potential
clamped at -60 mV as the resting potential of the differ-
entiated neurons. The currents were recorded with
borosilicate pipettes with resistances of 2–6MΩ, filled
with an internal solution containing (in): 140 mM K
Gluconate, 20 mM HEPES, 2 mM MgCl2, 4 mM K2ATP,
2 mM NaCl, 1 mM EGTA, and 2 mM NaCl, with pH
and osmolarity of the solutions being adjusted to 7.2 and
290 mOsm respectively. The external solution was com-
posed of 150 mM NaCl, 5 mM KCl, 2 mM CaCl2,
10 mM HEPES, 1 mM MgCl2, 10 mM glucose with the
pH and osmolarity of the solution being adjusted to 7.2
and 310 mOsm respectively. Transplanted neurons were
clamped using a MultiClamp 700A amplifier in conjunc-
tion with a Digidata 1322A interface (Molecular Devices
Inc., Sunnyvale, CA, USA). Currents were recorded and
analyzed using the pCLAMP software (Molecular De-
vices Inc., Sunnyvale, CA, USA).
10 μm brain slices sectioned with a vibrotome were
also stained with haematoxylin and eosin to determine
whether there is any teratoma formation by the trans-
planted cells. Briefly, sections were fixed in 4 % (w/v)
paraformaldehyde and washed in PBS for 4 times
followed by 1 min staining with haematoxylin. Samples
were then rinsed in distilled deionised water until no dye
can be extracted from the samples, followed with eosin
staining for 2mins. Samples were then washed, dehy-
drated and mounted on glass slides.
Statistical analysis
Numerical data of experimental and control groups were
analyzed with one-way Anova Bonferroni post-hoc
multi-group comparison, utilizing the SPSS software. A
value of P < 0.05 was considered statistically significant.
Results
LDN193189 treatment restricts hESC lineage fate to
neuroectoderm
During gastrulation in embryo development, bone mor-
phogenetic protein 4 (BMP4) is expressed in the embryo
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at the time of ectodermal fate determination. The ner-
vous system forms when BMP4 signaling is inhibited
[15]. Treatment with the BMP4 inhibitor LDN193189
results in effective induction of neural cells from hESCs
[16]. Studies in mouse embryonic stem cells have also
shown that the cells assume a primitive neural stem cell
Fig. 1 Under defined culture condition, when cells were treated with LDN193189 for 24 h, cells remained Nestin+ (a, red) and DCX+ (b, red) after
7 days of culture in EB medium. After lineage restriction and 5 days continuous culture in Neural basal medium supplemented with N2, 84.55 ±
1.14 % of the cells were Nestin+ (c), 96.9 ± 1.58 % of the cells were Pax6+ (d), 89.14 ± 3.15 % of the cells were SOX2+ (e) and 90.95 ± 3.6 % of the
cells were SOX1+ (f). Neural plate (NP) markers IRX3, SIX3 and OTX2, FP markers FOXA2 and NTN1, and neuroepithelial cell markers SOX2 and
PAX6 are all highly expressed after 5 days (g). Scale bars: A, B, 500 μm
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fate in the absence of extrinsic influences within in vitro
culture [17]. We conducted a preliminary screening
study whereby neural marker expression of hESC was
analyzed after treatment with increasing dosages (1, 2
and 5nM) of LDN193189 for varying durations of 24 h,
48 h and 72 h. Untreated hESC was utilized as the con-
trol. The results (Additional file 3: Figure S1) showed
that treatment with 2nM LDN193189 for 24 h yielded
the highest neural marker expression on average, as
compared to other dosages. Although there was marked
increase in SOX1 expression after 48 h treatment with
2nM LDN193189, low cell viability was observed. Hence,
we initially treated hESC with a dosage of 2 μM
LDN193189 for 24 h. After LDN193189 treatment for
24 h, the cells remain restricted to Nestin+ (Fig. 1a) and
DCX+ (Fig. 1b) neuroectodermal fate, even after 7 days
of culture in ES medium without FGF2. After
LDN193189 treatment and 5 days of continuous culture
in N2 supplemented culture medium, the four selected
neuroectoderm markers were all up-regulated, with
84.55 ± 1.14 % of the cells expressing Nestin+ (Fig. 1c),
96.9 ± 1.58 % of the cells expressing Pax6+ (Fig. 1d),
89.14 ± 3.15 % of the cells expressing SOX2+ (Fig. 1e)
and 90.95 ± 3.6 % of the cells expressing SOX1+ (Fig. 1f ).
In addition, neural plate (NP) markers: IRX3, SIX3, and
OTX2; FP markers: FOXA2, and NTN1, and general
neuroepithelial cell markers: SOX2 and PAX6 are all
highly expressed after 5 days of culture (Fig. 1g).
Dual inhibition produces medial FP cells
To further optimize the differentiation condition, 0.5nM
LDN193189 was continuously added to the induction
medium, but no differences in gene expression levels of
neural markers were observed. However, the proportion of
Nestin+ cells increased slightly to 93.38 ± 0.22 %, with no
significant changes in the expression of the other 3
markers: Pax6, SOX2 and SOX1 (Fig. 2a). Similar to BMP4
inhibition, the TGF-β inhibitor SB431542, which also tar-
gets downstream SMAD signaling, has also been reported
to have potent effects on neural induction of hESCs [18,
19]. Additionally, dual SMAD inhibition has been proven
to efficiently convert hESCs to the neural lineage [20].
Fig. 2 a Following LDN193189 restriction for 24 h, when cells were cultured under N2, N2 and LDN193189, or dual inhibition medium, the
percentage of Nestin+ cells increased from 84.55 ± 1.14 % to 96.84 ± 1.33 %. By contrast, no obvious changes were observed for Pax6+, SOX1+
and SOX2+ cells. b Compared with hESCs, OCT4 expression was downregulated significantly only after LDN193189 restriction followed by dual
inhibition. NANOG was downregulated significantly after LDN193189 restriction followed by N2, N2 and LDN193189 or dual inhibition medium.
c After LDN193189 restriction, when cells were cultured in dual inhibition medium for 5 days, Pax6 expression increased significantly compared
with undifferentiated hESCs, culture in N2 supplemented medium or LDN193189 inhibition for 5 days. d After lineage restriction with LDN193189
treatment, 5 days of dual inhibition resulted in significantly higher levels of neural gene expression comparing with the other treatment groups.
e After dual lineage restriction, 5 days of continuous LDN1931898 inhibition or dual inhibition resulted in a significantly lower percentage of
SOX1+ cells. n = 3 for each group
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When both LDN193189 and SB431542 were added to the
induction medium (dual inhibition), Pluripotency marker
OCT4 and NANOG were downregulated to an undetect-
able level (Fig. 2b). NP markers SOX1, SIX3, and FGF5; FP
markers FOXA2 and NTN1, were all up-regulated (Fig. 2d).
Specifically, PAX6 was up-regulated by 60-fold (Fig. 2c) and
the proportion of Nestin+ cells significantly increased again
up to 96.84 ± 1.33 % (Fig. 2a). Interestingly, when SB431542
was applied earlier during the first 24 h of culture, dual re-
striction alone followed by induction medium had the same
effect as initial treatment with LDN193189 (24 h) followed
by dual inhibition (5 days) on cellular expression of Nestin,
Pax6, SOX2 and SOX1 (Fig. 2e). Continuous inhibition
with LDN193189 for 5 days after dual restriction with both
LDN193189 and SB431542 for the first 24 h, resulted in a
reduction of the proportion of SOX1+ cells to 31.16 ±
2.82 %; whereas continuous dual restriction with both
LDN193189 and SB431542 for the first 24 h followed by
dual inhibition for 5 days significantly reduced the SOX1+
population to 16.88 ± 3.48 % (Fig. 2e).
FGF2 inhibits neural induction and inhibiting FGF2
signaling sustains NP state
Following the dual inhibition protocols, we further ex-
plored the role of FGF2 signaling in FP induction or
patterning. Inactivation of FGF signaling has been re-
ported to disable neural induction from ESCs [21]. It has
been argued that FGF2 signaling inhibits neural induc-
tion of hESCs and inhibition of FGF2 signaling blocks
ESCs entering the epiblast-like intermediate stage [22].
In our differentiation system, after dual restriction with
both LDN193189 and SB431542 for the first 24 h, when
hESCs have already entered into the NP stage, we found
that applying FGF2 for a further 5 days under the dual
inhibition protocol resulted in significant down regula-
tion of most neural lineage markers SOX1, FGF5,
LMX1A, and MASH1 (Fig. 3a). When FGF2 signaling
was continuously inhibited, a severe reduction in cell
number was observed. Transient FGF inhibition with
PD173074 in the LDN193189 restriction and dual inhib-
ition system resulted in no difference in expression of
any of the neural markers. However, when the same
24 h inhibition was performed with PD173074 together
with dual inhibition with both LDN193189 and
SB431542, a significant up-regulation of SOX1, FGF5,
LMX1A and MASH1 was observed (Fig. 3b). Sox1+ cells
increased to 32.28 ± 4.89 % after the transient inhibition
(Fig. 3c), suggesting that transient FGF2 inhibition slows
the progression of neural differentiation and sustains the
NP state. After dual inhibition, the cells morphologically
Fig. 3 a Under dual restriction and dual inhibition, when FGF2 were supplemented to the culture medium during dual inhibition, SOX1, FGF5,
LMX1A and MASH1 were all significantly down-regulated. b Under dual restriction and dual inhibition, when PD173074 were added to the culture
medium on day 1, there was significant up-regulation of SOX1, FGF5, LMX1A and MASH1 expression. c Under dual restriction and dual inhibition,
a significantly higher percentage of SOX1+ cells was observed for cells treated with PD173074 on day 1 only and harvested on day 5, as compared to the
absence of PD173074 treatment. d Morphologically, cells formed networked structures on day 5 when switched to differentiation medium from restriction
medium. e After 5 days of culture, Nestin+ (Red) and Tuj1+ (Green) were found co-localized within the colonies formed. f When sub-cultured, columnar
neural rosettes were observed on day 10. gWhen sub-cultured, columnar neural rosettes were SOX2+ (Red) and Tuj1+ (Green) on day 10. Cell nuclei were
stained with DAPI (Blue). Scale Bars: D, 100 μm. E, F & G, 200 μm. n= 3 for each group
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formed networked structures when switched to differen-
tiation medium with or without transient PD173074
treatment (Fig. 3d). After 5 days, Nestin+ and Tuj1+
(neuron-specific class III beta-tubulin) cells were found
to be co-localized within the colonies formed (Fig. 3e).
When sub-cultured, columnar neural rosettes were
formed on day 10 (Fig. 3f ) with the cells being SOX2+
and Tuj1+ (Fig. 3g).
Characterization of FP cell derived dopaminergic neurons
in vitro
After differentiation with the optimized dual restriction and
dual inhibition protocol, cells were subjected to patterning
with Shh and FGF8. Immunohistochemical staining for
neuronal structural markers and dopaminergic neuron
markers was performed after 10 days of patterning, and we
observed that the cells were Tuj1+ and Nurr1+ (Fig. 4a). In
addition, we also characterized the electrophysiological
properties and dopamine release profiles of these cells as
CaMKII+ and DAT+ (Fig. 4b). Flow cytometry analysis after
10 days of patterning showed that differentiated cells de-
rived from dual restriction and LDN193189 inhibition, dual
restriction and dual inhibition, where the majority of the
population are SOX1−, were more than 98 % Nurr1+ and
TH+. For the dual inhibition and normal induction proto-
cols, where cells were SOX1+, only 4.57 ± 0.9 % of the cells
were Nurr1+ (Fig. 4c). In vitro dopamine release from the
cells was also quantified with ELISA after 13 days of pat-
terning. Dopamine release increased from 3.50 ± 0.25 ng/
ml to 4.16 ± 0.56 ng/ml after 28 days of patterning. After
5 μM amantadine treatment, dopamine release increased to
3.7 ± 0.39 ng/ml on day13 and 4.48 ± 0.23 ng/ml on day18.
After 10 μM treatment, there was no further increase in
dopamine release on day13. However, dopamine release in-
creased to 4.64 ± 0.20 ng/ml on day 18 (Fig. 4d). The in-
crease in dopamine release reflects the functional
maturation of the dopaminergic neurons over time. When
comparing neurite outgrowth after differentiation from FP
and neurosphere derived cells, over a 90 h duration, it was
observed that the FP derived cells were more active in
neurite outgrowth than the neurosphere derived cells.
Upon comparing the neurite length at 4 h after seeding, FP
derived cells displayed 2.6 folds increment in neurite length,
whereas neurosphere derived cells displayed only 1.7 folds
increment in neurite length (Fig. 4e).
FP derived dopaminergic neurons are functional in vitro,
survive after transplantation and ameliorate behavioral
deficits in PD rats
Before FP derived dopaminergic neurons were trans-
planted into the PD rat model, whole-cell patch clamp
was performed on cultured cells after 20 days of
Fig. 4 After dual restriction and dual inhibition, cells were subsequently patterned with Shh and FGF8. Cells were Tuj1+ (a Green) and Nurr1+
(a Red), CaMKII+ (b Green) and DAT+ (b Red) after 10 days of patterning. Cell nuclei were stained with DAPI (Blue). c After 10 days of patterning,
for cells subjected to dual lineage restriction followed by culture in N2 supplemented medium, 4.57 ± 0.9 % of the cells were Nurr1+, as
compared to more than 98 % of Nurr1+ cells with continuous LDN193189 treatment or dual inhibition. d Dopamine release was found to
increase continuously after patterning for up to 28 days. When 5 and 10 μM of amantadine were added to the culture medium, higher
dopamine secretion levels were observed and a plateau was reached on day 25 of patterning. e Compared with neurons generated from
neurosphere, neurons generated from dual restriction and dual inhibition from hESCs single cells displayed a significantly higher neurite
outgrowth rate over 90 h culture. Scale Bar: A, B, 100 μm. n = 3 for each group
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differentiation to investigate their electrophysiological
functions. When the cell was exposed to a current of
140pA for 10 ms, membrane potential was found polar-
ized immediately and depolarized after the current was
applied. When a current was applied at 70pA for 10 ms,
membrane potential at polarization and depolarization
was observed with a delay (Fig. 5a). Similarly, upon ap-
plication of a 140pA current for 10 ms, depolarization of
the cell membrane induced the opening of NaV channels,
resulting in the influx of Na+ into the cells. Subse-
quently, opening of KV channels resulted in efflux of K
+
out of the cells (Fig. 5b).
After transplantation of cells into the stratum of the
host, tissue samples were collected from animals at week
4, 6, and 8 to assess cell survival and integration with β-
III tubulin immunostaining. At 4 weeks, a large number
of cells were found to have survived within the host with
positive staining for β-III tubulin (Fig. 5c). After 6 weeks,
integration was clearly observable with transplanted cell
interspersed with host cells (Fig. 5d). Some cells were
found to have migrated from the injection site to the
surrounding host tissue by week 8. Confocal microscopy
revealed that some cells have migrated across the host
nucleus (Fig. 5e). After H&E staining of the host tissue,
no obvious teratoma formation was found at both low
and high magnifications (Fig. 5f ). Over 8 weeks, clear ac-
tion potentials were recorded from grafted cells within
the host. When tissues were extracted for electrophysio-
logical studies of the grafted cells, action potentials were
induced when the cells were exposed to a current of 150
pA for 400 ms (Fig. 5g). The appearance of the action
potentials indicates that the cells already had the key
functional property of neurons.
In host rat tissues harvested at 8 weeks after trans-
plantation, there was positive staining with a human-
specific anti-tyrosine hydroxylase antibody utilized as a
Fig. 5 Differentiated dopaminergic cells were subjected to patch clamp analysis. a When the cell was exposed to a current of 140pA for 10 ms,
membrane potential was found polarized immediately and depolarized after application of the current. When exposed to a current of 70pA for
10 ms, the membrane potential of polarization and depolarization was observed with a delay. b Upon exposure to a current of 140pA for 10 ms,
depolarization of cell membrane induced the opening of NaV channels, which in turn resulted in an influx of Na
+ into the cells. Subsequently,
opening of KV channels resulted in an efflux of K
+ out of the cells. c After transplanting the cells into hemi-parkinsonian rats, a large number of
cells were found to have survived in the host with positive staining for Tuj1 (neuron-specific class III beta-tubulin) at 4 weeks post-surgery. d After
6 weeks following transplantation, integration was clearly observable with the transplanted cells interspersed with the host cells. e Confocal
microscopy showed that some cells have migrated across the host brain nucleus. f H&E staining of the host did not show any obvious teratoma
formation. g Over 8 weeks, when tissues were extracted for electrophysiological studies of grafted cells, action potentials were induced when the
cells were exposed to a current of 150 pA for 400 ms. Scale bars: C, D, E, 100 μm. F, 1 mm. Total number of rats transplanted with cells/control
culture media is 6 for each group
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human-specific and dopaminergic cell-specific marker
(Fig. 6a). To further investigate graft-host interaction, a
rat specific vascular marker CD31 was targeted together
with counterstaining that employed a human specific
Nurr1 antibody in host tissue (Fig. 6b). At 8 weeks after
transplantation, amphetamine induced ipslateral rotation
in the treatment group displayed a significant reduction
compared to the control sham-transplanted group
(Fig. 6c). Similar to amphetamine induced ipslateral ro-
tations, improvements in apomorphine induced contra-
lateral rotations also displayed a significant reduction
compared to the control at week 8 (Fig. 6d). To assess
motor activities, animals were studied with rota rod and
a significant increase in latency to fall was observed in
groups of animals transplanted with the cells, as com-
pared to the sham-transplanted controls (Fig. 6e).
Discussion
Within the FP, there are two distinct populations of cells
located in the lateral and medial regions of the FP. It is
generally agreed that all FP cells express netrin1, FOXA2
and Shh. However, there is controversy over the origin
of FP cells during early embryonic development,
particularly the role of notochord in FP induction [23].
Inhibition studies revealed that FP differentiation is im-
peded along the entire AP axis in mice and chick upon
pharmacological blockade of Shh (which is mainly
expressed in the notochord) [24, 25]. Gain of function
studies demonstrated that high concentrations of Shh in-
duced formation of FP tissue/cells from neural explants
and in vitro hESCs culture [8, 26]. Contrarily, loss of
function studies in zebra fish revealed unaffected ventral
midline differentiation with certain effects on lateral FP
induction [27]. Additionally, the finding that surgical ab-
lation of notochord resulted in lack of FP formation was
challenged by Nicole and colleagues, who postulated
that the absence of FP in notochord ablation experi-
ments was due to removal of FP precursors of nodal ori-
gin rather than termination of Shh secretion [28].
It has been shown that Shh is required for lateral FP
cell induction, but not for medial FP cells [29]. Medial
FP cells are still formed in the absence of a differentiated
notochord, thus indicating that Shh signaling originating
from the neural tube is not a prerequisite for MFP in-
duction [30, 31]. Additionally, medial FP cells failed to
develop in the case of mutations affecting the nodal-
Fig. 6 a In host rat tissue harvests at 8 weeks post-transplantation, there was positive staining with a human-specific anti-tyrosine hydroxylase
(Red) antibody utilized as a human-specific and dopaminergic cell-specific marker. b Grafted cell and host vascular congruency were clearly observed after
CD31 (Green) staining, which was both rat-specific and an endothelial cell specific marker. c At 8 weeks post-transplantation, amphetamine
induced ipslateral rotation in the treatment group was significantly reduced, as compared to the control sham-transplanted group. d There
was a significant reduction in apomorphine induced contra-lateral rotations compared to the control at 8 weeks post-transplantation. e Animals
were studied with rota rod and a significant increase in latency to fall was observed in groups of transplanted animals compared to the
sham-transplanted controls. Scale bars: A, 200 μm. B, 100 μm
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related molecule of the TGF-β family despite high levels
of Shh expression [32]. It was also reported that signal-
ing from the notochord or medial FP cells can induce
lateral FP cells [33]. These data suggest that with differ-
entiating FP cells within in vitro culture, the induction
of medial FP cells will also increase the population of lat-
eral FP cells. In this study, it was observed that FP cells,
both medial and lateral, can be induced without extrinsic
Shh treatment, thus supporting the hypothesis that the
developmental fate of FP cells are pre-determined before
being exposed to patterning signals from the notochord.
It is well established that dorsalization is mediated by
BMP and TGF-β signaling, which originate from the epi-
dermis and roof plate [34, 35]. Contrarily, antagonists of
the BMP and TGF-β family are known to be secreted
from the organizer to protect surrounding cells from
dorsalization [36]. BMP4 inhibition from the organizer is
required to induce neural differentiation of epiblast cells.
However, synchronized TGF-β inhibition stabilizes and
accelerates neural induction towards FP lineage fates.
We found that dual restriction under defined culture
conditions committed the lineage fate of hESCs to neu-
roectoderm in only 24 h. Further culture under dual inhib-
ition sustained neural differentiation in favor of the FP
lineage fate. Additionally, upon addition of FGF2, the ma-
jority of the anterior neural lineage markers were down-
regulated, suggesting that after neural induction of hESCs,
in the early phase of neurogenesis, high levels of FGF2 in-
hibits the anterior neural fate by up-regulating pluripo-
tency markers OCT4 and NANOG expression. It has
been shown that FGF2 acts as a morphogen for the an-
teroposterior axis of the CNS and that FGF2 induces gas-
trula ectoderm cells to express posterior neural markers in
Xenopus [37]. Other studies have shown that FGF2 cauda-
lizes intermediate neural tissue, inducing spinal cord for-
mation from anterior tissue [38]. In our in vitro culture
system, endogenous FGF2 could act in two ways simultan-
eously, ensuring cell survival and inducing differentiation
into caudal neural tissues. In this study, when FGF2 in-
hibitor is added to the culture for only 24 h, significant FP
induction was observed and maintained. Our data thus in-
dicates that neural conversion occurs in the presence of
weak FGF signaling combined with BMP inhibition, and
that pre-gastrulation FGF signaling is required in the ecto-
derm for the emergence of neural lineage fates [39].
Hence, inhibition of FGF signaling should be in a temporal
manner to ensure cell survival during neural induction. In
combination with ventralization factors that block BMP
and TGF-β signaling, SOX1− FP cells were induced after
5 days and these cells can be further induced into dopa-
minergic neurons efficiently. In contrast, despite the ex-
pression of other FP genes, dopaminergic cells cannot be
efficiently induced in culture when cells are still expressing
SOX1 and Nurr1.
Following the pioneering study of Kriks et al. [7], a
number of other studies have also attempted to utilize a
similar floor plate-based strategy for the derivation
dopaminergic neurons from human pluripotent stem
cells [40–43]. Nevertheless, all of these studies [40–43]
including that of Kriks et al. [7], carried out floor plate
induction through stimulation of the Shh signaling path-
way, either through the direct use of recombinant Shh
protein itself, or it’s agonist purmorphamine. Our study
differs from these previous studies by utilizing a Shh-
free approach to floor plate induction, through dual in-
hibition of the BMP4 (LDN193189) and TGF-β signaling
pathways (SB431542).
The results of this study demonstrated that the hESC-
derived dopaminergic neurons are functional in vitro,
can survive after transplantation and integrate within
the host brain. This is thus consistent with a previous
study which showed that grafted dopaminergic neurons
possess an intrinsic capacity for innervation of the adult
striatum [44]. Significant functional improvements were
observed in amphetamine induced ipslateral rotations,
apomorphine induced contra-lateral rotations and Rota
rod motor tests over a duration of 8 weeks post-
transplantation, and it is anticipated that the grafted cells
would continue to provide functional improvement at
later time points, because the long-term survival and
health of dopaminergic neuron transplants in Parkinson’s
disease patients over several years have been conclusively
demonstrated [45]. Nevertheless, it is unclear whether the
observed amelioration of behavioral deficits in the rat PD
model arise directly from new synaptic connectivity con-
ferred by the transplanted cells, or is instead due to other
pro-survival, neuroprotective or trophic effects of paracrine
secretions emanating from the transplanted cells. Although
the results of this study appear promising, we still need to
investigate what affects the survival of grafted cells in host,
how the grafted cell integrate with host and how the dopa-
mine release from grafted cells are controlled. By using an
optogenetic tool, we could be able to shut down the bio-
logical function of the grafted neurons within the host brain
and successfully created a temporal lapse of behavioral res-
toration in animal models. In a previous study [46], Wentz
and colleagues developed a wirelessly powered control LED
system for delivering light into specific areas of the brain.
Perhaps, we could utilize similar instrumentation for future
optogenetic studies to dissect the cellular and molecular
function of grafted dopaminergic neurons within the
rat brain.
Conclusion
We have demonstrated that when cells were predomin-
antly SOX1− under dual inhibition with both
LDN193189 and SB431542, FP cells can be generated ef-
ficiently. Following patterning with Shh and FGF8,
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midbrain dopaminergic neurons can be efficiently de-
rived at a very high yield. Our findings thus provide a
convenient approach to FP development and functional
dopaminergic neuron derivation.
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